melatonin

The medicinal product is indicated for the short-term treatment of jet lag in adults and for insomnia with difficulty falling asleep in children and adolescents (between 6 and 17 years old) with ADHD, when normal sleep routines are insufficient.

Form: solution, oral

ATC: N05CH01

Manufacturer: FARMA GROUP S.R.L.

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor sleep quality) in people over 55 years of age, when no medical, mental, or environmental cause has been identified.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: RAD NEURIM PHARMACEUTICALS EEC SARL

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor sleep quality) in people aged 55 years and older, when no medical, mental, or environmental cause has been identified.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: ECUPHARMA S.R.L.

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor sleep quality) in people over 55 years of age.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: ADOH B.V.

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor sleep quality) in people over 55 years of age.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: DOC GENERICI SRL

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor quality sleep) in patients over 55 years of age.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: RAD NEURIM PHARMACEUTICALS EEC SARL

It is used by adults for the short-term treatment of jet lag, i.e., the symptoms caused by the change in time zones during travel to the east or west.

Form: tablets

ATC: N05CH01

Manufacturer: VEMEDIA MANUFACTURING B.V.

It is used for the short-term treatment of primary insomnia (difficulty sleeping or poor quality sleep) in people aged 55 years and older.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: MYLAN S.P.A.

It is used for the short-term treatment of jet lag in adults and for insomnia with difficulty falling asleep in children and adolescents (between 6 and 17 years old) with attention deficit/hyperactivity disorder (ADHD), when normal sleep habits have not been sufficient.

Form: tablets

ATC: N05CH01

Manufacturer: ITALFARMACO S.P.A.

It is used to treat insomnia in children and adolescents with autism spectrum disorders or neurogenetic diseases (between 2 and 18 years old) and in those with ADHD (between 6 and 17 years old), when a healthy sleep routine has not been sufficient.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: RAD NEURIM PHARMACEUTICALS EEC SARL

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor sleep quality) in people aged 55 years and older, when no medical, mental, or environmental cause has been identified.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: PIAM FARMACEUTICI S.P.A.

It is used for the short-term treatment of jet lag in adults (aged 18 and over) and for insomnia with difficulty falling asleep in children and adolescents (aged 6 to 17 years) with attention deficit hyperactivity disorder (ADHD), when a healthy sleep routine has not been sufficient.

Form: tablets

ATC: N05CH01

Manufacturer: PIERPAOLI EXELYAS S.R.L.

It is used for the short-term treatment of primary insomnia (difficulty sleeping or poor quality sleep) in people aged 55 years and older, when no medical, mental, or environmental cause has been identified.

Form: tablets, prolonged-release

ATC: N05CH01

Manufacturer: I.B.N. SAVIO S.R.L